TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $51.9M invested in Theriva Biologics in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.03M
2
+$756K
3
+$755K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$238K
5
CS
Credit Suisse
Switzerland
+$213K

Top Sellers

1
-$5.84M
2
-$22K
3
-$18.9K
4
PP
Paloma Partners
Connecticut
-$18K
5
OC
Oppenheimer & Co
New York
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$52K
27
$46K
28
$44K
29
$42K
30
$37K
31
$32K
32
$26K
33
$24K
34
$23K
35
$21K
36
$17K
37
$14K
38
$11K
39
$8K
40
$6K
41
$4K
42
$3K
43
$1K
44
$8
45
–
46
–
47
–
48
–
49
–
1
2